Abstract:Bone Morphogenetic Proteins (BMPs) and other members of TGFβ superfamily regulate cell growth and differentiation. Abrogation of cellular responses to BMP/TGFβ is associated with human diseases such as cancer, cardiovascular, autoimmune and skeletal diseases. One of the most critical events in activation of BMP signal transduction pathway is the phosphorylation of transcription factor Smad1/5/8 (collective term for Smad1, Smad5 and Smad8) by BMP receptors. While phosphorylated Smad1/5/8 directly activate the BMP-induced gene transcription in the nucleus, protein phosphatases are anticipated to dephosphorylate phospho-Smad1/5/8 and consequently terminate BMP signaling. The identity of the long sought-after phosphatase has been one of the major unanswered questions in BMP/TGFβ biology. Objective: (1) To characterize how PPM1H physically interacts with and functionally dephosphorylate BMP-specific Smads, and (2) to investigate the functions of PPM1H in BMP-induced gene expression and osteoblast differentiation. Methods: We first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen for Smad phosphatases. BMP-induced Smad phosphorylation was analyzed using immunological methods such as immunoprecipitation, western blotting and immunofluorescence. Effects of PPM1H overexpression and knockdown on the level of Smad phosphorylation were determined by anti-phospho-Smad1 Western blotting. Real-time PCR, transcriptional analyses of BMP target genes and alkaline phosphatase assays were carried out to determine the functions of PPM1H in regulating BMP responses and osteoblast differentiation. Results: To identify the Smad phosphatases, we first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen. By using combined methods of functional genomics and biochemistry, we discovered that PPM1H represents a novel cytoplasm-localized Smad1/5/8-specific phosphatase. The effects of PPM1H on controlling the level of phosphorylated Smad1/5/8 (P-Smad1/5/8) were analyzed by immunological methods, e.g. immunofluorescence and western blotting, using a phospho-specific antibody against P-Smad1/5/8. PPM1H clearly dephosphorylated P-Smad1/5/8 in vivo and in vitro. In vitro binding, immunoprecipitation, and bimolecular fluorescence complementation assays demonstrated that PPM1H and Smad1 directly interact with each other in the cytoplasm. Consequently, ectopic expression of PPM1H in cells abolished BMP-induced gene expression as measured by real-time PCR and transcriptional reporter assays, and loss of PPM1H activity (site mutagenesis) or expression (RNA interference) greatly enhanced BMP signaling and osteoblast differentiation. Conclusion: PPM1H acts as a gatekeeper to prevent excessive BMP signal transduction through dephosphorylation and subsequent nuclear exclusion of Smad1/5/8. Our results not only gain insights into the important role of BMP signaling in human growth and development, but also are pertinent towards novel therapeutic approaches for the prevention and treatment of human diseases.

Intracellular signaling of osteogenic protein-1 through Smad5 activation.

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.

[The Role of Smads and Related Transcription Factors in the Signal Transduction of Bone Morphogenetic Protein Inducing Bone Formation].

Smad1 Interacts with Homeobox DNA-binding Proteins in Bone Morphogenetic Protein Signaling

Transforming Growth Factor Beta Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors

Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses

Bone Morphogenetic Protein-Smad Pathway As Drug Targets for Osteoporosis and Cancer Therapy

Transforming Growth Factor-1 Downregulation of Smad 1 Gene Expression in Rat Hepatic Stellate Cells

Post-translational regulation of TGF-β receptor and Smad signaling.

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Oncostatin M suppresses bone morphogenetic protein‐4‐induced osteoprotegerin synthesis in MC3T3‐E1 osteoblast‐like cells: p70 S6 kinase attenuation

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects.

Signal Transduction of Bone Morphogenetic Proteins in Osteoblast Differentiation.

Regulation of Cell Proliferation by Smad Proteins

Smad Protein and Tgf-Beta Signaling in Vascular Smooth Muscle Cells.

Novel Phosphatase PPM1H Controls BMP Signaling and Osteoblast Differentiation

Smad1 Stabilization and Delocalization in Response to the Blockade of BMP Activity